✦ LIBER ✦

P-241 In vivo effect of 5-azacitidine treatment in regulatory T cells in patients with AML/MDS

✍ Scribed by Buenasmañanas, D.; Serrano-López, J.; Serrano, J.; Casaño, J.; García-Torres, E.; Martinez-Losada, C.; Chic, C.; Llamas, M.J.; Figueroa, V.; Sánchez-García, J.

Book ID: 123019780
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 91 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/S0145-2126(13)70288-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-163 Efficacy and tolerablity of azacit

P-163 Efficacy and tolerablity of azacitidine treatment in patients with MDS, AML and CMML

✍ Biedma, A.; Avellaneda, C.; Berruga, J.; Tallón, D.; Ferrer, C.; Anguita, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

P-301 Results of 5-azacitidine therapy i

P-301 Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)

✍ Freyrie, A.; Reda, G.; Vincenti, D.; Ferla, V.; Orofino, N.; Sciumè, M.; Guidott 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 86 KB

P-276 High doses of eltrombopag are well

P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML

✍ Dickinson, M.; Herbert, K.; Sardjono, C.; Le, T.; Link, E.; Zannino, D.; Ruell, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

P-121 BCL2L10 is associated with resista

P-121 BCL2L10 is associated with resistance to azacitidine (AZA) in MDS and AML, and is a possible target in resistant patients

✍ Cluzeau, T.; Robert, G.; Karsenti, J.M.; Luciano, F.; Legrand, F.; Mannone, L.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 138 KB

O-021 Patterns of infection in patients

O-021 Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis

✍ Falantes, J.; Calderón, C.; Márquez-Malaver, F.J.; Aguilar, M.; Martino, M.L.; G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Idarubicin in combination with cytarabin

Idarubicin in combination with cytarabine and VP-16 in the treatment of post-MDS AML patients

✍ Pogliani, E.M.; Baldicchi, L.; Pioltelli, P.; Miccolis, I.R.; Mangiagalli, M.; C 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 91 KB